Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPV1 | Q8NER1 | 18/20 | 0.55 |
| ▸ | CCNE1 | P24864 | 1/20 | 0.52 |
| ▸ | CDK2 | P24941 | 1/20 | 0.52 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.52 |
| ▸ | SSTR4 | P31391 | 1/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4776317 | 0.82 | TRPV1 (0.60) | TRPV1CCNE1CDK2CDK5 | |
| SCHEMBL5660097 | 0.81 | TRPV1 (0.71) | TRPV1CCNE1CDK2CDK5 | |
| SCHEMBL1351616 | 0.81 | PRKCZ (0.70) | TRPV1CCNE1CDK2CDK5 | |
| SCHEMBL4776314 | 0.81 | TRPV1 (0.56) | TRPV1 | |
| SCHEMBL14860966 | 0.80 | EPHX1 (0.70) | TRPV1CCNE1CDK2CDK5 | |
| SCHEMBL4780255 | 0.80 | TRPV1 (0.54) | TRPV1CCNE1CDK2CDK5SSTR4 | |
| SCHEMBL4780432 | 0.80 | CCNE1 (0.49) | TRPV1CCNE1CDK2CDK5SSTR4 | |
| SCHEMBL4779001 | 0.80 | TRPV1 (0.49) | TRPV1CCNE1CDK2CDK5SSTR4 | |
| SCHEMBL13595613 | 0.79 | EPHX1 (0.72) | TRPV1CCNE1CDK2CDK5 | |
| Hydrochloric Acid SCHEMBL4780347 | 0.79 | TRPV1 (0.58) | TRPV1CCNE1CDK2CDK5CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008010061-A2 | 3-AZABICYCLO [3.1.0] HEXANE VANILLOID RECEPTOR LIGANDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND PROCESSES FOR THEIR PREPARATION | GLENMARK PHARMACEUTICALS S.A. (US) | 2008-01-24 | — | — | WO | disclosed |